期刊文献+

小剂量他克莫司用于尸肾移植的短期疗效及安全性

原文传递
导出
摘要 目的探讨小剂量他克莫司(Tac)用于尸肾移植的短期疗效及安全性。方法将2007年1月至2009年5月在我院接受肾移植的108例患者,根据供肾来源的不同分为两组:尸体肾移植组51例,活体肾移植组57例。所有患者术后均接受小剂量Tac+吗替麦考酚酯(MMF)+强的松(Pred)治疗。术后分别随访6个月,收集两组患者的基本资料,分析术后急性排斥反应发生率,肺部感染发生率,肾功能延迟恢复发生率,术后肝、肾功能指标。结果两组患者术前资料除热(冷)缺血时间(P均=0.000)外,差异无统计学意义;术后两组患者的急性排斥反应发生率、肺部感染发生率、肾功能延迟恢复发生率、术后肝功能差异无统计学意义;肾功能在术后第1、2周差异有统计学意义(P〈0.05)。结论肾移植术后患者Tac+MMF+Pred三联用药,在使用足够剂量MMF(1.0~2.0g/d)的情况下,使用小剂量Tac0.025-0.05mg/(kg·d)用于尸肾移植,是安全有效的。
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期1068-1070,共3页 Journal of Sichuan University(Medical Sciences)
  • 相关文献

参考文献9

  • 1Margreiter R. Efficacy and safety of tacrolimus compared with eielosporin microemulsion in renal transplantation, a randomised multieentre study. Lancet,2002,359(9308):741-746. 被引量:1
  • 2Osuna A, Gentil MA, Capdevila L, et al. Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors>55 years of age. Transplant Proc,2005,37(3) :1438-1440. 被引量:1
  • 3Peters TG, Shaver TR, Ames JE, et al. Cold ischemia and outcome in 17, 937 cadaveric kidney transplants. Transplantation, 1995 ; 59 (2) : 191-196. 被引量:1
  • 4Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation: the multivariate analysis. Transplantation, 1995;59(7) :962-968. 被引量:1
  • 5American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator- associated, and healthcar-associated pneumonia. Am J Respir Crit Care Med,2005,171(4) :388-416. 被引量:1
  • 6Koning OH, Ploeg RJ, Van Bockel JH, etal. Risk factors for delayed graft function in eadaveric kidney transplantation : a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi- organ donors. European Multicenter Study Group. Transplantation, 1997 ; 63 (11) :1620-1628. 被引量:1
  • 7Starzl TE, Todo S, Fung J, et al. FK-506 for liver, kidney, and pancreas transplantation. Lancet, 1989,2 (8670): 1000- 1004. 被引量:1
  • 8Plosker GL, Foster RH. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs,2000 ,59 (2) : 323-389. 被引量:1
  • 9Ekberg H, Grinyo J, Nashan B, etal. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticostetoids in renal allograft recipients: the CAESAR Study. Am J Transplant, 2007 7(3) :560-570. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部